- Home
- AFYA vs TVTX Comparison
AFYA vs TVTX Comparison
Compare AFYA & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFYA
- TVTX
- Stock Information
- Founded
- AFYA 1999
- TVTX 2008
- Country
- AFYA Brazil
- TVTX United States
- Employees
- AFYA N/A
- TVTX N/A
- Industry
- AFYA Other Consumer Services
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- AFYA Real Estate
- TVTX Health Care
- Exchange
- AFYA Nasdaq
- TVTX Nasdaq
- Market Cap
- AFYA 1.6B
- TVTX 1.5B
- IPO Year
- AFYA 2019
- TVTX N/A
- Fundamental
- Price
- AFYA $15.06
- TVTX $18.82
- Analyst Decision
- AFYA Sell
- TVTX Strong Buy
- Analyst Count
- AFYA 5
- TVTX 16
- Target Price
- AFYA $17.40
- TVTX $33.40
- AVG Volume (30 Days)
- AFYA 127.2K
- TVTX 1.5M
- Earning Date
- AFYA 08-13-2025
- TVTX 08-06-2025
- Dividend Yield
- AFYA 1.54%
- TVTX N/A
- EPS Growth
- AFYA 23.45
- TVTX N/A
- EPS
- AFYA 1.39
- TVTX N/A
- Revenue
- AFYA $650,778,153.00
- TVTX $333,865,000.00
- Revenue This Year
- AFYA $15.42
- TVTX $71.61
- Revenue Next Year
- AFYA $8.73
- TVTX $43.45
- P/E Ratio
- AFYA $11.07
- TVTX N/A
- Revenue Growth
- AFYA 15.60
- TVTX 87.94
- 52 Week Low
- AFYA $13.47
- TVTX $8.46
- 52 Week High
- AFYA $19.90
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- AFYA 48.88
- TVTX 74.85
- Support Level
- AFYA $14.58
- TVTX $15.60
- Resistance Level
- AFYA $15.88
- TVTX $17.46
- Average True Range (ATR)
- AFYA 0.42
- TVTX 0.83
- MACD
- AFYA 0.22
- TVTX 0.26
- Stochastic Oscillator
- AFYA 64.79
- TVTX 98.44
About AFYA Afya Limited
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.